Vol. XVIII · Free shipping $75+ · Read the collection
Login Register
Feature · Product Review
c ebpβ-lip drug

c ebpβ-lip drug Facts Continuous Activation of C/EBPβ Transcription – C/EBPβ sustains the oncogenic program

C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology C EBP LIP induces a tumor menagerie making it an oncogene Journal of Molecular Medicine Springer Nature Link C EBP LIP induces cancer type metabolic reprogramming by regulating the let 7 LIN28B circuit in mice Communications Biology Purified anti C EBP beta 3 isoforms C EBP beta, LAP, LIP Antibody anti C EBP beta 1H7

SKU: 93278539425 · From iglepidom.org

4.7
USD24.22 USD67.22

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

- Nattokinase c kh nng tc ng a chiu vo c ch lm tan huyt khi

c ebp-lip drug Facts Continuous Activation of C/EBP Transcription C/EBP sustains the oncogenic program

doi: 10.1091/mbc.e05-07-0650 130 MehtaD

c ebp-lip drug Facts Continuous Activation of C/EBP Transcription C/EBP sustains the oncogenic program

2D-LDA score plot

c ebp-lip drug Facts Continuous Activation of C/EBP Transcription C/EBP sustains the oncogenic program

At least 10,000 events were collected and data were analysed using FlowJo software (Tree Star Inc.)

c ebp-lip drug Facts Continuous Activation of C/EBP Transcription C/EBP sustains the oncogenic program
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products